Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10786938
rs10786938 		T 0.700 GeneticVariation GWASCAT Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. 30988330

2019
dbSNP: rs11084596
rs11084596 		T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs11199879
rs11199879 		C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs141179786
rs141179786 		0.700 GeneticVariation GWASCAT Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. 30988330

2019
dbSNP: rs148678804
rs148678804 		A 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs17144046
rs17144046 		G 0.700 GeneticVariation GWASCAT A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). 28656603

2017
dbSNP: rs200476
rs200476 		A 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs2555019
rs2555019 		C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs6078585
rs6078585 		T 0.700 GeneticVariation GWASCAT Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. 30988330

2019
dbSNP: rs7906649
rs7906649 		G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs1024611
rs1024611 		0.010 GeneticVariation BEFREE No association was observed between the CCL2 rs1024611 polymorphism and BPH. 30816510

2019
dbSNP: rs103294
rs103294 		0.010 GeneticVariation BEFREE Association between rs103294, BPH risk and clinicopathological traits were tested with adjustment for age. rs103294 was significantly associated with BPH risk with a p-value of 0.0067. 23615473

2013
dbSNP: rs10983755
rs10983755 		0.010 GeneticVariation BEFREE The mutant alleles of rs10983755 (G>A) and rs1927907 (G>A) tended to put on risk of BPH</span>, yet the wide alleles of rs4986791 (C>T) and rs115336889 (G>C) were associated with incremental susceptibility to BPH (<i>P</i><0.05). 30944713

2019
dbSNP: rs12826786
rs12826786 		0.010 GeneticVariation BEFREE The rs12826786 T allele was significantly more presented in both BPH and prostate cancer groups compared with healthy subjects. 28259691

2017
dbSNP: rs16902947
rs16902947 		0.010 GeneticVariation BEFREE rs16902947, rs16902947 and rs4646437 single nucleotide polymorphisms are significantly associated with the clinical characteristics of benign prostatic hyperplasia and the efficacy of benign prostatic hyperplasia treatment. 28787260

2017
dbSNP: rs2735839
rs2735839 		0.010 GeneticVariation BEFREE In this case-control study, rs2735839 was genotyped in 532 patients with PC and 602 controls with benign prostate hyperplasia (BPH) using polymerase chain reaction-restriction fragment length polymorphism assay. 31017705

2019
dbSNP: rs1034866440
rs1034866440
AR
0.010 GeneticVariation BEFREE The SRD5A2 polymorphisms A49T, V89L and R227Q, the androgen receptor CAG and GGN repeats and sex hormone status was investigated in men with prostate cancer (CaP) (n=89), benign prostate hyperplasia (n=45) and healthy military conscripts (n=223). 16039774

2005
dbSNP: rs137852569
rs137852569
AR
0.010 GeneticVariation BEFREE The SRD5A2 polymorphisms A49T, V89L and R227Q, the androgen receptor CAG and GGN repeats and sex hormone status was investigated in men with prostate cancer (CaP) (n=89), benign prostate hyperplasia (n=45) and healthy military conscripts (n=223). 16039774

2005
dbSNP: rs6152
rs6152
AR
0.010 GeneticVariation BEFREE To investigate the relationships between male androgenetic alopecia, androgen receptor (AR) gene polymorphism (SNP rs6152) and clinical characteristics of BPH and prostate cancer. 24665929

2015
dbSNP: rs3803185
rs3803185
ARL11
0.010 GeneticVariation BEFREE Cys148Arg genotypes and expression of the ARLTS1 were explored in a large set of familial and unselected PCa cases, clinical tumor samples, xenografts, prostate cancer cell lines and benign prostatic hyperplasia (BPH) samples. 22028916

2011
dbSNP: rs2556378
rs2556378
BCL11A
T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs72878024
rs72878024
BET1L ; ODF3
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs4938723
rs4938723
BTG4 ; MIR34B ; MIR34C ; LOC728196
0.010 GeneticVariation BEFREE This case-control study was done on 151 prostate cancer (PCa) patients and 152 benign prostate hyperplasia to examine whether rs4938723 polymorphism in the promoter of pri-miR-34b/c was linked to the carcinogenesis of PCa in a sample of Iranian population. 27983526

2017
dbSNP: rs10035432
rs10035432
C5orf46
0.010 GeneticVariation BEFREE We found an inverse association between SNP rs10035432 and BPH under the log-additive (p=0.007) model. 26124326

2015
dbSNP: rs677394
rs677394
C5orf66
C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018